Back
Immatics N.V. IMTX · Insights
Immatics N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing T-ce... Price6.43
Market Cap962.16 M
Float127.72 M
CountryDE
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro